Annual accounts
Unaudited abridged accounts
31/08/2027Filing deadline
Made up to 30/11/2025Due 31/08/2027
- Next accounts made up to
- 30/11/2026
- Last accounts made up to
- 30/11/2025
REFINE PHARMA LTD
ActiveRegistry details
Reference data exactly as held at Companies House.
Copy registry details
- Registered office
- 80 St. Georges Road, Bolton BL1 2DD
- Classification (SIC)
- Manufacture of pharmaceutical preparations (21.20 - SIC 2007)
- Accounts type
- Unaudited abridged
Company activity
The 4 most recent documents filed at Companies House.
Pre-Score for UK companies is coming soon
- 27/08/2026View PDF (8 pages)
Unaudited abridged accounts made up to 2025-11-30
- 26/02/2026View PDF (2 pages)
Change of details for Refine Bs Holdings Limited as a person with significant control on 2026-02-26
- 26/02/2026View PDF (1 pages)
Director's details changed for Refine Bs Holdings Limited on 2026-02-26
- 22/01/2026View PDF (1 pages)
Cessation of Bradley Tyson as a person with significant control on 2026-01-22
Coming soon
What Pre-Score will tell you
- Whether the filed accounts are strengthening or weakening year on year.
- Whether this company files on time, and how often its record changes.
- How its officers and controlling parties connect to other UK companies.
Accounts and confirmation statement
The two filings Companies House requires every year, and where each one stands against its deadline today.
On schedule
Confirmation statement
Confirms the registry record is up to date
05/02/2027Filing deadline
Last statement 22/01/2026Due 05/02/2027
- Next statement date
- 22/01/2027
- Last statement dated
- 22/01/2026
Financial performance
The latest figures REFINE PHARMA LTD filed. Okredo holds filed accounts data for 2022–2025; the year-by-year record is on the financials page.
Net Assets
£554.53K2025
68.74%vs 20242024: £328.64K
Total Assets
£3.01M2025
52.33%vs 20242024: £1.98M
Cash in Bank
£291.23K2025
-23.17%vs 20242024: £379.05K
Total Liabilities
£2.40M2025
48.40%vs 20242024: £1.61M
Employees
92025
0vs 20242024: 9
Of the 4 measures with an earlier filing to compare against, 3 rose and 1 fell. Total assets moved furthest, up 52.33% on 2024. See the full financial analysis for REFINE PHARMA LTD.
The full financial record
Four ways through REFINE PHARMA LTD's filed accounts — the year-by-year numbers, the compound rates and the ratios behind them.
Net Assets · +69.4% a year (CAGR)Three-year trend, 2023–2025Every measure end to end across 2023, 2024 and 2025, with the compound rate behind each one.See what moved5 chartsCharts by indicator5 filed indicators plotted year by year, 2022–2025.Plot the figuresNothing estimatedRatios from the filed figures4 ratios computed from this company's own reported amounts, each shown against the year it was derived from.Check the ratios5 × 4 yearsEvery figure by yearAll 5 measures Okredo tracks across 4 reported years, exactly as filed.Open the table
Employees
Headcount as reported to Companies House for 2022–2025.
| Year | Employees | Change |
|---|---|---|
| 2025 | 9 | 0 |
| 2024 | 9 | +2 |
| 2023 | 7 | +5 |
| 2022 | 2 | – |
Reported employee count increased from 2 in 2022 to 9 in 2025. See how headcount moved alongside the reported financials.
Credit report
It is a professional assessment of the company 's performance, revealing company's potential and risks, showing it's past experiences and revealing future prospects.
- Company potential
- Risk indicators
- Past performance
- Future prospects
Officers
4Directors, secretaries and other appointed officers, with the period each has served.
| Person | Role | Period | Connected companies |
|---|---|---|---|
| Director | 15/03/2023–Present | 6 | |
| Director | 08/11/2021–02/01/2023 | 9 | |
| Director | 08/11/2021–01/07/2025 | 11 | |
| Corporate Director | 02/02/2023–Present | 7 |
Persons with significant control
5Individuals or entities with significant control over the company, as declared to Companies House.
| Person | Period | Connected companies |
|---|---|---|
| 08/11/2021–Present | 6 | |
| 08/11/2021–22/01/2026 | 6 | |
| 08/11/2021–Present | 11 | |
| 08/11/2021–02/12/2025 | 11 | |
| 22/01/2026–Present | 7 |
Filing history and recent activity
Every document on the Companies House record, newest first.
- Filings on record
- 25
- Since 07/11/2022
- Last 12 months
- 11
- +5 vs the year before
- Most recent filing
- 27/08/2026
- 1 month ago
What changed in the last year
- Accounts filedLatest 27/08/2026
- Officer changes (7)Latest 26/02/2026
- Confirmation statement (3)Latest 22/01/2026
Filing timeline
- 27/08/2026View PDF (8 pages)
Unaudited abridged accounts made up to 2025-11-30
- 26/02/2026View PDF (2 pages)
Change of details for Refine Bs Holdings Limited as a person with significant control on 2026-02-26
- 26/02/2026View PDF (1 pages)
Director's details changed for Refine Bs Holdings Limited on 2026-02-26
- 22/01/2026View PDF (1 pages)
Cessation of Bradley Tyson as a person with significant control on 2026-01-22
- 22/01/2026View PDF (1 pages)
Director's details changed for Refine Bs Holdings Limited on 2026-01-22
- 22/01/2026View PDF (2 pages)
Notification of Refine Bs Holdings Limited as a person with significant control on 2026-01-22
- 22/01/2026View PDF (4 pages)
Confirmation statement made on 2026-01-22 with updates
- 02/12/2025View PDF (2 pages)
Change of details for Mr Bradley Tyson as a person with significant control on 2025-12-02
- 02/12/2025View PDF (1 pages)
Cessation of Jarnail Singh Kang as a person with significant control on 2025-12-02
- 02/12/2025View PDF (4 pages)
Confirmation statement made on 2025-12-02 with updates
- 11/11/2025View PDF (3 pages)
Confirmation statement made on 2025-11-07 with no updates
- 28/08/2025View PDF (8 pages)
Unaudited abridged accounts made up to 2024-11-30
Showing 12 of 25 filings
See when the next accounts and confirmation statement are due
Similar companies
11 UK companies are similar to REFINE PHARMA LTD, sharing the same company status (Active), the same industry sector and activity group (Manufacture of pharmaceutical preparations) and a comparable number of employees. The 5 closest matches are shown below to help you compare competitors and industry peers.
BITEBACK PRODUCTS LTD
ActiveThe Cottage High Street, Rowde, Devizes SN10 2PL
- Activity
- Manufacture of basic pharmaceutical products
- Company no.
- 10652689
- Incorporated
- 06/03/2017
- Employees
- 9
MACOPHARMA (UK) LIMITED
Active11 Old Jewry, London EC2R 8DU
- Activity
- Manufacture of basic pharmaceutical products
- Company no.
- 01986987
- Incorporated
- 07/02/1986
- Employees
- 9
J.L.BRAGG (IPSWICH) LIMITED
ActiveC/O John Phillips & Co Ltd, 81 Centaur Court Claydon, Business Park Great Blakenham, Ipswich Suffolk IP6 0NL
- Activity
- Manufacture of pharmaceutical preparations
- Company no.
- 01029805
- Incorporated
- 04/11/1971
- Employees
- 8
G.H. ZEAL LIMITED
Active8 Deer Park Road, London, SW19 3UU
- Activity
- Manufacture of basic pharmaceutical products
- Company no.
- 02474574
- Incorporated
- 27/02/1990
- Employees
- 9
CAMBRIDGE HEALTHCARE SUPPLIES LIMITED
ActiveUnit 1 Wymondham Business Park, Chestnut Drive, Wymondham, Norfolk NR18 9SB
- Activity
- Manufacture of basic pharmaceutical products
- Company no.
- 03463709
- Incorporated
- 11/11/1997
- Employees
- 9
About REFINE PHARMA LTD
A short description of the company, written from its Companies House record.
REFINE PHARMA LTD is a private limited company registered in the United Kingdom, based in 80 St. Georges Road, Bolton BL1 2DD. Companies House classifies its business as Manufacture of pharmaceutical preparations. It has been on the register for 4 years 10 months.
The register currently records it as active. Its 2025 accounts report net assets of £554.53K and 9 employees.
REFINE PHARMA LTD: frequently asked questions
Answered from this company's own registry record and filed figures.
Companies House records REFINE PHARMA LTD under one registered business activity: Manufacture of pharmaceutical preparations (21.20 - SIC 2007).
REFINE PHARMA LTD is recorded as active on the Companies House register, and has been on it since 08/11/2021.
The most recent accounts Okredo holds cover 2025 and report net assets of £554.53K, total assets of £3.01M, cash in bank of £291.23K and total liabilities of £2.40M.
The most recent document on the record is dated 27/08/2026: Unaudited abridged accounts made up to 2025-11-30, 1 month ago.
On the current registry record, accounts are due by 31/08/2027 and the next confirmation statement is due by 05/02/2027.
Companies House lists 4 officers (2 currently in post) and 5 people with significant control (3 current).